Comparison Chart Quest Diagnostics Incorporated

Stocks

DGX

US74834L1008

Healthcare Facilities & Services

Market Closed - NYSE Other stock markets 16:00:02 2026-07-17 EDT			5-day change	1st Jan Change
210.68 ^USD	+0.61%		+1.56%	+21.41%

07-15	Leerink Partners Adjusts Quest Diagnostics Price Target to $244 From $240, Maintains Outperform Rating	MT
07-08	Quest Diagnostics Incorporated Integrates Oncology Test Access with Flatiron Health Oncoemr for American Oncology Network	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	QUEST DIAGNOSTICS INCORPORATED	Other Healthcare Facilities & Services	+0.61%	+1.56%	+21.41%	+26.22%	+54.63%	23.32B